Skip to content
10-Q

Quarterly Report

NEOS THERAPEUTICS, INC.

0001558370-20-006303

← back to feed
Filed
May 11, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · May 4, 2020 49.75M sh
Capex Q1 2020 · Mar 31, 2020 $160K
Capex Q1 2020 · Mar 31, 2019 $167K
Operating Cash Flow Q1 2020 · Mar 31, 2020 −$999K
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$6.1M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $27.86M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $16.83M
Stockholders Equity Q1 2020 · Mar 31, 2020 −$13.18M
Stockholders Equity Q1 2020 · Dec 31, 2019 −$6.13M
Stockholders Equity Q1 2020 · Mar 31, 2019 $1.13M
Current Liabilities Q1 2020 · Mar 31, 2020 $68.4M
Current Liabilities Q1 2020 · Dec 31, 2019 $63.36M
Current Assets Q1 2020 · Mar 31, 2020 $65.75M
Current Assets Q1 2020 · Dec 31, 2019 $66.56M
Total Assets Q1 2020 · Mar 31, 2020 $89.09M
Total Assets Q1 2020 · Dec 31, 2019 $90.87M
Sga Expense Q1 2020 · Mar 31, 2020 $4.37M
Sga Expense Q1 2020 · Mar 31, 2019 $3.79M
Rd Expense Q1 2020 · Mar 31, 2020 $2.04M
Rd Expense Q1 2020 · Mar 31, 2019 $3.2M
Net Income Q1 2020 · Mar 31, 2020 −$7.95M
Net Income Q1 2020 · Mar 31, 2019 −$7.6M
Operating Income Q1 2020 · Mar 31, 2020 −$5.89M
Operating Income Q1 2020 · Mar 31, 2019 −$5.82M
Gross Profit Q1 2020 · Mar 31, 2020 $8.1M
Gross Profit Q1 2020 · Mar 31, 2019 $8.24M
Cost Of Revenue Q1 2020 · Mar 31, 2020 $6.39M
Cost Of Revenue Q1 2020 · Mar 31, 2019 $6.4M
Revenue Q1 2020 · Mar 31, 2020 $14.49M
Revenue Q1 2020 · Mar 31, 2019 $14.63M